Oral effectiveness of beta adrenergic antagonists in preventing epinephrine-induced metabolic responses.
D000818:Animals; D004285:Dogs; D004336:Drug Antagonism; D004837:Epinephrine / Q000037:antagonists & inhibitors*; D006943:Hyperglycemia / Q000139:chemically induced; D007545:Isoproterenol / Q000494:pharmacology; D007773:Lactates / Q000097:blood; D009638:Norepinephrine / Q000494:pharmacology; D051381:Rats; D013565:Sympatholytics / Q000494:pharmacology*
D007773:Lactates; D013565:Sympatholytics; D007545:Isoproterenol; D009638:Norepinephrine; D004837:Epinephrine